文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

以色列德鲁兹少数民族终末期肾病患者遗传标记研究

Genetic Markers Among the Israeli Druze Minority Population With End-Stage Kidney Disease.
PubMed 文献 · Am J Kidney Dis · 2023-09-15

本研究对以色列德鲁兹族接受维持性透析的终末期肾病患者进行全国多中心横断面外显子测序,94例成人中17例(18%)发现遗传病因,最常见为新发群体特异性WDR19纯合致病变异。外显子前临床诊断与最终分子诊断一致者不足半数。

要点

  • 德鲁兹族ESKD患者外显子测序遗传诊断率约18%,均无既往分子诊断。
  • 最常见遗传发现为新发群体特异性WDR19纯合致病变异(p.Cys293Tyr)。
  • 外显子前临床诊断与最终分子诊断一致者不足半数。

核心结论

  • 外显子测序在约18%的德鲁兹ESKD患者中识别出遗传诊断,支持在高CKD患病率且表型疾病特异性可能较低的少数民族人群中进行遗传分析。

研究设计与样本

  • 全国多中心横断面研究,纳入以色列德鲁兹族接受维持性透析的ESKD成人94例,占研究期间以色列全部97例透析德鲁兹患者的97%,所有参与者接受外显子测序。

主要发现

  • 94例参与者中17例(18%)发现遗传病因,均无既往分子诊断。
  • 新发群体特异性WDR19纯合致病变异(p.Cys293Tyr)是最常见遗传发现。
  • 其他单基因病因包括PKD1、PKD2、IV型胶原突变及非传染性疾病的单基因形式。
  • 外显子前临床诊断与最终分子诊断一致者不足半数。

临床怎么用

  • 结果支持在高CKD患病率且表型疾病特异性可能较低的少数民族人群中进行遗传分析。

局限性

  • 研究仅限于德鲁兹个体,普遍性可能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Genetic etiologies have been identified among approximately 10% of adults with chronic kidney disease (CKD). However, data are lacking regarding the prevalence of monogenic etiologies especially among members of minority groups. This study characterized the genetic markers among members of an Israeli minority group with end-stage kidney disease (ESKD). STUDY DESIGN: A national-multicenter cross-sectional study of Israeli Druze patients (an Arabic-speaking Near-Eastern transnational population isolate) who are receiving maintenance dialysis for ESKD. All study participants underwent exome sequencing. SETTING & PARTICIPANTS: We recruited 94 adults with ESKD, comprising 97% of the total 97 Druze individuals throughout Israel being treated with dialysis during the study period. PREDICTORS: Demographics and clinical characteristics of kidney disease. OUTCOME: Genetic markers. ANALYTICAL APPROACH: Whole-exome sequencing and the relationship of markers to clinical phenotypes. RESULTS: We identified genetic etiologies in 17 of 94 participants (18%). None had a previous molecular diagnosis. A novel, population-specific, WDR19 homozygous pathogenic variant (p.Cys293Tyr) was the most common genetic finding. Other monogenic etiologies included PKD1, PKD2, type IV collagen mutations, and monogenic forms of noncommunicable diseases. The pre-exome clinical diagnosis corresponded to the final molecular diagnosis in fewer than half of the participants. LIMITATIONS: This study was limited to Druze individuals, so its generalizability may be limited. CONCLUSIONS: Exome sequencing identified a genetic diagnosis in approximately 18% of Druze individuals with ESKD. These results support conducting genetic analyses in minority populations with high rates of CKD and for whom phenotypic disease specificity may be low. PLAIN-LANGUAGE SUMMARY: Chronic kidney disease (CKD) affects many people worldwide and has multiple genetic causes. However, there is limited information on the prevalence of genetic etiologies, especially among minority populations. Our national-multicenter study focused on Israeli Druze patients. Using exome-sequencing, we identified previously undetected genetic causes in nearly 20% of patients, including a new and population-specific WDR19 homozygous pathogenic variant. This mutation has not been previously described; it is extremely rare globally but is common among the Druze, which highlights the importance of studying minority populations with high rates of CKD. Our findings provide insights into the genetic basis of end-stage kidney disease in the Israeli Druze, expand the WDR19 phenotypic spectrum, and emphasize the potential value of genetic testing in such populations.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Shlomovitz O, Atias-Varon D, Yagel D, et al. Genetic Markers Among the Israeli Druze Minority Population With End-Stage Kidney Disease. Am J Kidney Dis. 2023. PMID: 37717846. doi:10.1053/j.ajkd.2023.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。